JP2000510701A5 - - Google Patents

Download PDF

Info

Publication number
JP2000510701A5
JP2000510701A5 JP1997541036A JP54103697A JP2000510701A5 JP 2000510701 A5 JP2000510701 A5 JP 2000510701A5 JP 1997541036 A JP1997541036 A JP 1997541036A JP 54103697 A JP54103697 A JP 54103697A JP 2000510701 A5 JP2000510701 A5 JP 2000510701A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997541036A
Other languages
English (en)
Other versions
JP2000510701A (ja
JP4476362B2 (ja
Filing date
Publication date
Priority claimed from US08/648,235 external-priority patent/US6268487B1/en
Application filed filed Critical
Publication of JP2000510701A publication Critical patent/JP2000510701A/ja
Publication of JP2000510701A5 publication Critical patent/JP2000510701A5/ja
Application granted granted Critical
Publication of JP4476362B2 publication Critical patent/JP4476362B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2000510701
Figure 2000510701
Figure 2000510701
Figure 2000510701
JP54103697A 1996-05-13 1997-05-13 生物学的に活性なペプチドのミルクからの精製 Expired - Lifetime JP4476362B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/648,235 1996-05-13
US08/648,235 US6268487B1 (en) 1996-05-13 1996-05-13 Purification of biologically active peptides from milk
PCT/US1997/008044 WO1997042835A1 (en) 1996-05-13 1997-05-13 Purification of biologically active peptides from milk

Publications (3)

Publication Number Publication Date
JP2000510701A JP2000510701A (ja) 2000-08-22
JP2000510701A5 true JP2000510701A5 (ja) 2005-01-13
JP4476362B2 JP4476362B2 (ja) 2010-06-09

Family

ID=24599969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54103697A Expired - Lifetime JP4476362B2 (ja) 1996-05-13 1997-05-13 生物学的に活性なペプチドのミルクからの精製

Country Status (14)

Country Link
US (1) US6268487B1 (ja)
EP (1) EP0923308B1 (ja)
JP (1) JP4476362B2 (ja)
AT (1) ATE224145T1 (ja)
AU (1) AU725993B2 (ja)
CA (1) CA2254871C (ja)
DE (2) DE122007000008I2 (ja)
DK (1) DK0923308T3 (ja)
ES (1) ES2182074T3 (ja)
LU (1) LU91305I2 (ja)
NL (1) NL300256I2 (ja)
NZ (1) NZ332916A (ja)
PT (1) PT923308E (ja)
WO (1) WO1997042835A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7478333B2 (ja) 2020-07-29 2024-05-07 和弘 原 成分調整物生産装置及び成分調整物生産方法

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I1 (de) 1986-04-09 2007-05-16 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
AP1678A (en) 1997-10-20 2006-11-27 Gtc Biotherapeutics Inc Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
SE9802213D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab A method for the removal/purification of serum albumins and means for use in the method
US20030005468A1 (en) * 1998-06-19 2003-01-02 Meade Harry M. Methods and vectors for improving nucleic acid expression
AU6104799A (en) * 1998-09-24 2000-04-10 Ppl Therapeutics (Scotland) Limited Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
DK1148779T3 (da) * 1999-01-06 2008-03-25 Merrimack Pharmaceuticals Inc Ekspression af secerneret humant alpha-fötoprotein i transgene dyr
EP1194570A1 (en) 1999-06-23 2002-04-10 PPL Therapeutics (Scotland) Limited Fusion proteins incorporating lysozyme
WO2001085192A1 (en) * 2000-05-05 2001-11-15 Gtc Biotherapeutics, Inc. Transgenically produced decorin
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20040226053A1 (en) * 2000-10-13 2004-11-11 Meade Harry M. Methods of producing a target molecule in a transgenic animal and purification of the target molecule
CN1525977A (zh) * 2001-06-13 2004-09-01 陶洛斯Hsa有限责任公司 人血清白蛋白的纯化
US7285631B2 (en) * 2001-08-10 2007-10-23 Serono Genetics Institute S.A. Human cDNAs and proteins and uses thereof
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20060253913A1 (en) * 2001-12-21 2006-11-09 Yue-Jin Huang Production of hSA-linked butyrylcholinesterases in transgenic mammals
WO2003090545A1 (en) * 2002-04-24 2003-11-06 Dairy Development Specialists, Inc. Intermediate ingredient for dairy product manufacturing and method of making the same
EP1367065B1 (en) * 2002-05-27 2008-07-30 Nestec S.A. Acid soluble proteins from micellar casein
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20040092719A1 (en) * 2002-09-17 2004-05-13 Eszter Birck-Wilson Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
JP2006507839A (ja) * 2002-11-27 2006-03-09 ジーティーシー バイオセラピューティックス インコーポレイテッド 乳中に安定して産生される改変抗体およびその製造方法
US20040231010A1 (en) * 2003-01-09 2004-11-18 Murray James D. Lysozyme transgenic ungulates
US20040210953A1 (en) * 2003-01-09 2004-10-21 Murray James D. Lysozyme transgenic ungulates
US20040248262A1 (en) 2003-01-22 2004-12-09 Koeberl Dwight D. Constructs for expressing lysomal polypeptides
RU2005129745A (ru) * 2003-02-24 2006-03-20 Джитиси Байотерапьютикс, Инк. (Us) Способы и устройство проточной фильтрации вдоль потока
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
US20050245444A1 (en) * 2004-04-30 2005-11-03 Yann Echelard Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) * 2004-12-07 2006-06-08 Yann Echelard Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
US20060130159A1 (en) * 2004-12-09 2006-06-15 Nick Masiello Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
WO2006138647A2 (en) * 2005-06-16 2006-12-28 Gtc Biotherapeutics, Inc. Method of making recombinant human antibodies for use in biosensor technology
WO2007014244A2 (en) * 2005-07-25 2007-02-01 Gtc Biotherapeutics, Inc. Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
EP2388272A1 (en) * 2005-10-21 2011-11-23 GTC Biotherapeutics, Inc. Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
FR2901707B1 (fr) 2006-05-31 2017-09-29 Lab Francais Du Fractionnement Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
US20090208480A1 (en) * 2006-08-04 2009-08-20 Yue Huang Long half-life recombinant butyrylcholinesterase
FR2910786B1 (fr) * 2006-12-29 2017-08-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) "procede d'extraction d'une proteine presente dans du lait"
JP5208428B2 (ja) * 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
FR2912310B1 (fr) 2007-02-13 2009-08-07 Kasan Sarl Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
NZ583234A (en) 2007-07-10 2012-06-29 Glanbia Nutritionals Method for removing endotoxin from proteins
TWI346666B (en) * 2007-12-31 2011-08-11 Animal Technology Inst Taiwan Method for seperating casein from casein-contained solution
EP2077273B1 (en) 2007-12-31 2011-09-14 Animal Technology Institute Taiwan Methods for separating casein from soluble proteins in a composition
US8304005B2 (en) * 2008-04-21 2012-11-06 Fuji Oil Company, Limited Method for production of defatted soymilk peptide
EP2279003A4 (en) * 2008-05-01 2013-04-03 Gtc Biotherapeutics Inc ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF INFLAMMATORY DISEASES
US9247766B2 (en) * 2008-05-14 2016-02-02 Murray Goulburn Co-Operative Co., Limited Angiogenin-enriched milk fractions
SG10201407983VA (en) * 2009-12-18 2015-01-29 Csl Ltd Method of purifying polypeptides
AU2010340358B2 (en) 2009-12-21 2014-07-24 Pharmathene, Inc. Recombinant butyrylcholinesterases and truncates thereof
US8861162B2 (en) * 2010-03-09 2014-10-14 Honeywell International Inc. High power solid state power controller (SSPC) solution for primary power distribution applications
FR2958496A1 (fr) * 2010-04-09 2011-10-14 Bioprotein Technologies Sa Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques.
CN103002878B (zh) 2010-04-09 2015-07-01 帕西拉制药有限公司 用于配制大直径合成膜囊泡的方法
WO2012045769A1 (en) 2010-10-05 2012-04-12 Novo Nordisk Health Care Ag Process for protein production
SG191781A1 (en) 2010-12-30 2013-08-30 Lab Francais Du Fractionnement Glycols as pathogen inactivating agents
EP2694196B1 (en) 2011-04-01 2021-07-21 EMD Millipore Corporation Nanofiber containing composite structures
AU2012278836B2 (en) * 2011-07-07 2016-03-10 Lfb Usa, Inc. Formulations that stabilize proteins
TW201400499A (zh) 2012-03-12 2014-01-01 Revo Biolog Inc 抗凝血酶用於治療妊娠毒血症之用途
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
WO2014022748A1 (en) 2012-08-03 2014-02-06 Revo Biologics, Inc. The use of antithrombin in extracorporeal membrane oxygenation
CA2900909A1 (en) 2013-02-13 2014-08-21 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof
CN105263319A (zh) 2013-02-13 2016-01-20 法国化学与生物科技实验室 具有经修饰的糖基化的蛋白及其生产方法
PL3016729T3 (pl) 2013-07-05 2020-09-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Société Anonyme Matryca do chromatografii powinowactwa
US9661868B2 (en) * 2013-07-16 2017-05-30 Mead Johnson Nutrition Company Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
JP2017520531A (ja) * 2014-06-02 2017-07-27 ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーLaboratoire Francais du Fractionnement et des Biotechnologies Fc断片の産生
FR3034419B1 (fr) 2015-04-02 2017-12-15 Lab Francais Du Fractionnement Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
JP6786519B2 (ja) * 2015-04-17 2020-11-18 イー・エム・デイー・ミリポア・コーポレイシヨン 接線流濾過モードで作動するナノファイバー限外濾過膜を用いた、試料中の目的の生物学的物質を精製する方法
EP3805257A4 (en) * 2018-05-24 2022-03-16 Jiangsu Hengrui Medicine Co., Ltd. METHOD OF PRODUCTION OF A PRECURSOR OF RECOMBINANT HUMAN INSULIN OR ANALOGUE THEREOF
FR3082427B1 (fr) 2018-06-14 2020-09-25 Lab Francais Du Fractionnement Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
CN113101737B (zh) * 2021-03-04 2023-09-15 京美生命科技(杭州)有限公司 一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
FR2487642B2 (fr) 1980-07-31 1985-10-18 Bel Fromageries Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2584727B1 (fr) 1985-07-11 1988-06-17 Roussel Uclaf Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
JPS62298536A (ja) 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
DE3743440A1 (de) * 1987-12-21 1989-06-29 Gauri Kailash Kumar Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch
US4897465A (en) 1988-10-12 1990-01-30 Abbott Laboratories Enrichment and concentration of proteins by ultrafiltration
CA2351200A1 (en) 1989-12-01 1991-06-13 Gene Pharming Europe Bv Production of recombinant polypeptides by bovine species and transgenic methods
NL9001650A (nl) 1990-07-19 1992-02-17 Ver Coop Melkind Werkwijze voor de bereiding van een melkeiwit-isolaat.
US5256294A (en) * 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
US5175013A (en) 1990-12-31 1992-12-29 The Pillsbury Company Frozen dessert compositions and products
US5178894A (en) 1991-09-26 1993-01-12 Silvia P. Rudel High non-fat milk content bread products having improved keeping qualities
JP3670003B2 (ja) 1992-06-15 2005-07-13 ファーミング ビー.ブイ. ウシ種による組み換えポリペプチドの製造及びトランスジェニック法
US5256437A (en) * 1992-06-19 1993-10-26 Pall Corporation Product and process of making sterile milk through dynamic microfiltration
AU693436B2 (en) 1993-03-09 1998-07-02 Genzyme Corporation Isolation of components of interest from milk
WO1995022258A2 (en) 1994-02-16 1995-08-24 Pharming Bv Isolation of lactoferrin from milk
US5597486A (en) * 1995-05-01 1997-01-28 Millipore Investment Holdings Limited Membrane filtration with optimized addition of second liquid to maximize flux

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7478333B2 (ja) 2020-07-29 2024-05-07 和弘 原 成分調整物生産装置及び成分調整物生産方法

Similar Documents

Publication Publication Date Title
JP2000506989A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000507854A5 (ja)
JP2000501324A5 (ja)
JP2002511131A5 (ja)
JP2000510701A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000500874A5 (ja)
JP2001502172A5 (ja)
JP2000502485A5 (ja)
JP2000515107A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2001504107A5 (ja)
JP2000501744A5 (ja)
JP2000504793A5 (ja)
JP2000500857A5 (ja)
JP2000502316A5 (ja)
JP2001505937A5 (ja)
JP2000501229A5 (ja)
JP2000502714A5 (ja)